Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Other solid neoplasm 1Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Sarcoma 2Colorectal Neoplasms 2Uterine Cervical Neoplasms 1Squamous Non-small Cell Lung Cancer 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms, Multiple Primary 1Neoplasm Metastasis 1NSCLC 1Meningeal Carcinomatosis 1Lung Neoplasms 1Locally Advanced Rectal Carcinoma 1Histiocytoma, Malignant Fibrous 1HER2-positive Breast Cancer 1Gastrointestinal Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Diabetes Mellitus, Insulin-Dependent, 12 1Dermatofibrosarcoma 1Colonic Neoplasms 1Chondrosarcoma 1Carcinoma, Ovarian Epithelial 1Biliary Tract Neoplasms 1Advanced Pancreatic Cancer 1

Interventions

envafolimab 1durvalumab 1Nivolumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Locally Advanced Rectal Carcinoma × envafolimab × Clear all
NCT05645094 2022-12-13

Neoadjuvant Envafolimab in Resectable and Locally Advanced MSI-H/dMMR Rectal Cancer

Fudan University

Unknown
38 enrolled
GastrointestinalOther solid neoplasm

Locally Advanced Rectal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡